Akbari K - Search Results

1

Clinical, imaging, and blood biomarkers to assess 1-year progression risk in fibrotic interstitial lung diseases-Development and validation of the honeycombing, traction bronchiectasis, and monocyte (HTM)-score.

Shao G, Hawle P, Akbari K, Horner A, Hintenberger R, Kaiser B, Lamprecht B, Lang D. Shao G, et al. Among authors: akbari k. Front Med (Lausanne). 2022 Nov 16;9:1043720. doi: 10.3389/fmed.2022.1043720. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36465895 Free PMC article.

2

Determinants of underdiagnosis of COPD in national and international surveys.

Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, Burney P, Miravitlles M, García-Rio F, Akbari K, Ancochea J, Menezes AM, Perez-Padilla R, Montes de Oca M, Torres-Duque CA, Caballero A, González-García M, Buist S; BOLD Collaborative Research Group, the EPI-SCAN Team, the PLATINO Team, and the PREPOCOL Study Group. Lamprecht B, et al. Among authors: akbari k. Chest. 2015 Oct;148(4):971-985. doi: 10.1378/chest.14-2535. Chest. 2015. PMID: 25950276

3

Complications of CT-guided transthoracic lung biopsy : A short report on current literature and a case of systemic air embolism.

Lang D, Reinelt V, Horner A, Akbari K, Fellner F, Lichtenberger P, Lamprecht B. Lang D, et al. Among authors: akbari k. Wien Klin Wochenschr. 2018 Apr;130(7-8):288-292. doi: 10.1007/s00508-018-1317-0. Epub 2018 Jan 23. Wien Klin Wochenschr. 2018. PMID: 29362884 Free PMC article. Review.

4

Early serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated advanced NSCLC-A retrospective cohort study.

Lang D, Horner A, Brehm E, Akbari K, Hergan B, Langer K, Asel C, Scala M, Kaiser B, Lamprecht B. Lang D, et al. Among authors: akbari k. Lung Cancer. 2019 Aug;134:59-65. doi: 10.1016/j.lungcan.2019.05.033. Epub 2019 May 31. Lung Cancer. 2019. PMID: 31319996

5

Therapy Line and Associated Predictors of Response to PD-1/PD-L1-Inhibitor Monotherapy in Advanced Non-small-Cell Lung Cancer: A Retrospective Bi-centric Cohort Study.

Lang D, Huemer F, Rinnerthaler G, Horner A, Wass R, Brehm E, Akbari K, Granitz M, Hutarew G, Kaiser B, Greil R, Lamprecht B. Lang D, et al. Among authors: akbari k. Target Oncol. 2019 Dec;14(6):707-717. doi: 10.1007/s11523-019-00679-9. Target Oncol. 2019. PMID: 31654203 Free PMC article.

6

Computed tomography findings as determinants of pulmonary function tests in fibrotic interstitial lung diseases-Network-analyses and multivariate models.

Lang D, Akbari K, Walcherberger S, Hergan B, Horner A, Hepp M, Kaiser B, Pieringer H, Lamprecht B. Lang D, et al. Among authors: akbari k. Chron Respir Dis. 2020 Jan-Dec;17:1479973120967025. doi: 10.1177/1479973120967025. Chron Respir Dis. 2020. PMID: 33272023 Free PMC article.

7

Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study.

Lang D, Haslinger W, Akbari K, Scala M, Hergan B, Asel C, Horner A, Wass R, Brehm E, Kaiser B, Lamprecht B. Lang D, et al. Among authors: akbari k. Lung Cancer (Auckl). 2020 Dec 18;11:113-121. doi: 10.2147/LCTT.S286228. eCollection 2020. Lung Cancer (Auckl). 2020. PMID: 33376433 Free PMC article.

8

Computed Tomography Findings as Determinants of Local and Systemic Inflammation Biomarkers in Interstitial Lung Diseases: A Retrospective Registry-Based Descriptive Study.

Lang D, Akbari K, Horner A, Hepp M, Kaiser B, Pieringer H, Lamprecht B. Lang D, et al. Among authors: akbari k. Lung. 2021 Apr;199(2):155-164. doi: 10.1007/s00408-021-00434-w. Epub 2021 Mar 26. Lung. 2021. PMID: 33770227 Free PMC article.

9

First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict Outcomes.

Lang D, Ritzberger L, Rambousek V, Horner A, Wass R, Akbari K, Kaiser B, Kronbichler J, Lamprecht B, Gabriel M. Lang D, et al. Among authors: akbari k. Cancers (Basel). 2021 Dec 3;13(23):6096. doi: 10.3390/cancers13236096. Cancers (Basel). 2021. PMID: 34885206 Free PMC article.

10

Protocol for the Exercise, Cancer and Cognition - The ECCO-Study: A Randomized Controlled Trial of Simultaneous Exercise During Neo-/Adjuvant Chemotherapy in Breast Cancer Patients and Its Effects on Neurocognition.

Kiesl D, Kuzdas-Sallaberger M, Fuchs D, Brunner S, Kommenda R, Tischler C, Hornich H, Akbari K, Kellermair J, Blessberger H, Ocenasek H, Hofmann P, Zimmer P, Vosko MR. Kiesl D, et al. Among authors: akbari k. Front Neurol. 2022 Mar 25;13:777808. doi: 10.3389/fneur.2022.777808. eCollection 2022. Front Neurol. 2022. PMID: 35401389 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page